1. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 2017;38:2739–91. https://doi.org/10.1093/eurheartj/ehx391; PMID: 28886619.
2. Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016;374:1609–220. https://doi.org/10.1056/NEJMoa1514616; PMID: 27040324.
3. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Eng J Med 2019;380:1695–705. https://doi.org/10.1056/NEJMoa1814052; PMID: 30883058.
4. Paradis JM, Del Trigo M, Puri R, et al. Transcatheter valve-in-valve and valve-in-ring for treating aortic and mitral surgical prosthetic dysfunction. J Am Coll Cardiol 2015;66:2019–37. https://doi.org/10.1016/j.jacc.2015.09.015; PMID: 26516006.
5. Dvir D, Bourguignon T, Otto CM, et al. Standardized definition of structural valve degeneration for surgical and transcatheter bioprosthetic aortic valves. Circulation 2018;137:388–99. https://doi.org/10.1161/CIRCULATIONAHA.117.030729; PMID: 29358344.